PhiTech Bioinformatics
PhiTech is a genomics and bioinformatics company pioneering the integration of DNA and RNA sequencing data with artificial intelligence to support rare disease diagnostics. Their flagship product is the first RNA-Seq-based, AI-powered diagnostic decision support platform designed for rare disease patients who remain undiagnosed after DNA-based tests. The platform leverages RNA-Seq data to extract critical diagnostic information such as pathogenic variants, aberrantly expressed genes and transcripts, monoallelically expressed genes, and aberrantly spliced genes, enhancing diagnostic accuracy. PhiTech operates globally with offices in Turkey, the US, and Europe, and is positioned as a leader in precision medicine diagnostics for rare diseases.
PhiTech Bioinformatics
PhiTech is a genomics and bioinformatics company pioneering the integration of DNA and RNA sequencing data with artificial intelligence to support rare disease diagnostics. Their flagship product is the first RNA-Seq-based, AI-powered diagnostic decision support platform designed for rare disease patients who remain undiagnosed after DNA-based tests. The platform leverages RNA-Seq data to extract critical diagnostic information such as pathogenic variants, aberrantly expressed genes and transcripts, monoallelically expressed genes, and aberrantly spliced genes, enhancing diagnostic accuracy. PhiTech operates globally with offices in Turkey, the US, and Europe, and is positioned as a leader in precision medicine diagnostics for rare diseases.